Rapport Therapeutics, Inc.
RAPP
$38.08
$0.842.26%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 476.78M | 490.54M | 513.03M | 260.45M | 285.38M |
| Total Receivables | 58.00K | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 7.65M | 7.82M | 7.53M | 9.69M | 5.48M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 205.00K | 205.00K | 105.00K | 105.00K | 105.00K |
| Total Current Assets | 484.70M | 498.56M | 520.66M | 270.24M | 290.97M |
|
|
|||||
| Total Current Assets | 484.70M | 498.56M | 520.66M | 270.24M | 290.97M |
| Net Property, Plant & Equipment | 11.85M | 12.89M | 13.60M | 14.22M | 10.87M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.06M | 985.00K | 1.07M | 1.03M | 211.00K |
| Total Assets | 497.60M | 512.43M | 535.32M | 285.50M | 302.05M |
|
|
|||||
| Total Accounts Payable | 6.56M | 4.19M | 3.24M | 3.18M | 2.14M |
| Total Accrued Expenses | 8.72M | 12.10M | 8.60M | 6.94M | 6.24M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.62M | 2.76M | 2.48M | 1.76M | 1.01M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 17.90M | 19.05M | 14.32M | 11.88M | 9.38M |
|
|
|||||
| Total Current Liabilities | 17.90M | 19.05M | 14.32M | 11.88M | 9.38M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 8.19M | 8.73M | 9.39M | 10.10M | 6.83M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 26.09M | 27.78M | 23.71M | 21.98M | 16.22M |
|
|
|||||
| Common Stock & APIC | 727.10M | 719.34M | 712.94M | 438.13M | 433.74M |
| Retained Earnings | -255.09M | -235.23M | -201.47M | -174.54M | -147.81M |
| Treasury Stock & Other | -505.00K | 546.00K | 145.00K | -76.00K | -95.00K |
| Total Common Equity | 471.51M | 484.65M | 511.62M | 263.51M | 285.84M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 471.51M | 484.65M | 511.62M | 263.51M | 285.84M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 471.51M | 484.65M | 511.62M | 263.51M | 285.84M |
|
|
|||||